nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—skeletal joint—systemic scleroderma	0.0203	0.204	CbGeAlD
Ketorolac—PTGS1—artery—systemic scleroderma	0.00891	0.0894	CbGeAlD
Ketorolac—PTGS2—artery—systemic scleroderma	0.00852	0.0854	CbGeAlD
Ketorolac—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00769	0.624	CbGdCrCtD
Ketorolac—PTGS1—endothelium—systemic scleroderma	0.00753	0.0755	CbGeAlD
Ketorolac—PTGS2—endothelium—systemic scleroderma	0.00719	0.0722	CbGeAlD
Ketorolac—PTGS1—blood vessel—systemic scleroderma	0.00694	0.0696	CbGeAlD
Ketorolac—PTGS2—blood vessel—systemic scleroderma	0.00663	0.0665	CbGeAlD
Ketorolac—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00464	0.376	CbGdCrCtD
Ketorolac—PTGS1—connective tissue—systemic scleroderma	0.00356	0.0357	CbGeAlD
Ketorolac—PTGS2—connective tissue—systemic scleroderma	0.0034	0.0341	CbGeAlD
Ketorolac—PTGS1—smooth muscle tissue—systemic scleroderma	0.00326	0.0326	CbGeAlD
Ketorolac—PTGS1—skin of body—systemic scleroderma	0.00321	0.0322	CbGeAlD
Ketorolac—PTGS2—smooth muscle tissue—systemic scleroderma	0.00311	0.0312	CbGeAlD
Ketorolac—PTGS2—skin of body—systemic scleroderma	0.00307	0.0308	CbGeAlD
Ketorolac—PTGS1—digestive system—systemic scleroderma	0.00257	0.0258	CbGeAlD
Ketorolac—PTGS2—digestive system—systemic scleroderma	0.00246	0.0246	CbGeAlD
Ketorolac—PTGS1—tendon—systemic scleroderma	0.00245	0.0245	CbGeAlD
Ketorolac—PTGS2—tendon—systemic scleroderma	0.00234	0.0234	CbGeAlD
Ketorolac—PTGS1—lung—systemic scleroderma	0.00215	0.0215	CbGeAlD
Ketorolac—PTGS2—lung—systemic scleroderma	0.00205	0.0206	CbGeAlD
Ketorolac—Myocardial infarction—Prednisone—systemic scleroderma	0.000368	0.000415	CcSEcCtD
Ketorolac—Breast disorder—Methotrexate—systemic scleroderma	0.000368	0.000415	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000368	0.000414	CcSEcCtD
Ketorolac—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000414	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000367	0.000413	CcSEcCtD
Ketorolac—Hypersensitivity—Azathioprine—systemic scleroderma	0.000367	0.000413	CcSEcCtD
Ketorolac—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000366	0.000413	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000366	0.000413	CcSEcCtD
Ketorolac—Insomnia—Lisinopril—systemic scleroderma	0.000365	0.000411	CcSEcCtD
Ketorolac—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000411	CcSEcCtD
Ketorolac—Paraesthesia—Lisinopril—systemic scleroderma	0.000362	0.000408	CcSEcCtD
Ketorolac—Vomiting—Captopril—systemic scleroderma	0.000362	0.000408	CcSEcCtD
Ketorolac—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000406	CcSEcCtD
Ketorolac—Dyspnoea—Lisinopril—systemic scleroderma	0.00036	0.000405	CcSEcCtD
Ketorolac—Rash—Captopril—systemic scleroderma	0.000359	0.000405	CcSEcCtD
Ketorolac—Dermatitis—Captopril—systemic scleroderma	0.000359	0.000404	CcSEcCtD
Ketorolac—Somnolence—Lisinopril—systemic scleroderma	0.000359	0.000404	CcSEcCtD
Ketorolac—Headache—Captopril—systemic scleroderma	0.000357	0.000402	CcSEcCtD
Ketorolac—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000357	0.000402	CcSEcCtD
Ketorolac—Dyspepsia—Lisinopril—systemic scleroderma	0.000355	0.0004	CcSEcCtD
Ketorolac—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000354	0.000399	CcSEcCtD
Ketorolac—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000354	0.000399	CcSEcCtD
Ketorolac—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000398	CcSEcCtD
Ketorolac—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000398	CcSEcCtD
Ketorolac—Asthma—Methotrexate—systemic scleroderma	0.000352	0.000397	CcSEcCtD
Ketorolac—Infection—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000396	CcSEcCtD
Ketorolac—Decreased appetite—Lisinopril—systemic scleroderma	0.000351	0.000395	CcSEcCtD
Ketorolac—Eosinophilia—Methotrexate—systemic scleroderma	0.000349	0.000393	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000348	0.000392	CcSEcCtD
Ketorolac—Fatigue—Lisinopril—systemic scleroderma	0.000348	0.000392	CcSEcCtD
Ketorolac—Shock—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000392	CcSEcCtD
Ketorolac—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000391	CcSEcCtD
Ketorolac—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00039	CcSEcCtD
Ketorolac—Hypersensitivity—Leflunomide—systemic scleroderma	0.000346	0.00039	CcSEcCtD
Ketorolac—Pancreatitis—Methotrexate—systemic scleroderma	0.000345	0.000389	CcSEcCtD
Ketorolac—Pain—Lisinopril—systemic scleroderma	0.000345	0.000389	CcSEcCtD
Ketorolac—Constipation—Lisinopril—systemic scleroderma	0.000345	0.000389	CcSEcCtD
Ketorolac—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000389	CcSEcCtD
Ketorolac—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000387	CcSEcCtD
Ketorolac—Bradycardia—Prednisone—systemic scleroderma	0.000344	0.000387	CcSEcCtD
Ketorolac—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000385	CcSEcCtD
Ketorolac—Diarrhoea—Azathioprine—systemic scleroderma	0.00034	0.000383	CcSEcCtD
Ketorolac—Haemoglobin—Prednisone—systemic scleroderma	0.000339	0.000382	CcSEcCtD
Ketorolac—Nausea—Captopril—systemic scleroderma	0.000339	0.000381	CcSEcCtD
Ketorolac—Haemorrhage—Prednisone—systemic scleroderma	0.000337	0.00038	CcSEcCtD
Ketorolac—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00038	CcSEcCtD
Ketorolac—Asthenia—Leflunomide—systemic scleroderma	0.000337	0.00038	CcSEcCtD
Ketorolac—Hallucination—Prednisone—systemic scleroderma	0.000336	0.000378	CcSEcCtD
Ketorolac—Pancytopenia—Methotrexate—systemic scleroderma	0.000335	0.000377	CcSEcCtD
Ketorolac—Feeling abnormal—Lisinopril—systemic scleroderma	0.000333	0.000375	CcSEcCtD
Ketorolac—Pruritus—Leflunomide—systemic scleroderma	0.000332	0.000374	CcSEcCtD
Ketorolac—Connective tissue disorder—Prednisone—systemic scleroderma	0.000332	0.000373	CcSEcCtD
Ketorolac—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000372	CcSEcCtD
Ketorolac—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00033	0.000372	CcSEcCtD
Ketorolac—Dysuria—Methotrexate—systemic scleroderma	0.000329	0.000371	CcSEcCtD
Ketorolac—Dizziness—Azathioprine—systemic scleroderma	0.000329	0.00037	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000363	CcSEcCtD
Ketorolac—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000322	0.000362	CcSEcCtD
Ketorolac—Asthenia—Mycophenolic acid—systemic scleroderma	0.000322	0.000362	CcSEcCtD
Ketorolac—Diarrhoea—Leflunomide—systemic scleroderma	0.000321	0.000362	CcSEcCtD
Ketorolac—Urticaria—Lisinopril—systemic scleroderma	0.000321	0.000361	CcSEcCtD
Ketorolac—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00036	CcSEcCtD
Ketorolac—Abdominal pain—Lisinopril—systemic scleroderma	0.000319	0.000359	CcSEcCtD
Ketorolac—Body temperature increased—Lisinopril—systemic scleroderma	0.000319	0.000359	CcSEcCtD
Ketorolac—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000358	CcSEcCtD
Ketorolac—Pruritus—Mycophenolic acid—systemic scleroderma	0.000317	0.000357	CcSEcCtD
Ketorolac—Vomiting—Azathioprine—systemic scleroderma	0.000316	0.000356	CcSEcCtD
Ketorolac—Pneumonia—Methotrexate—systemic scleroderma	0.000316	0.000356	CcSEcCtD
Ketorolac—Eye disorder—Prednisone—systemic scleroderma	0.000315	0.000355	CcSEcCtD
Ketorolac—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000355	CcSEcCtD
Ketorolac—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000354	CcSEcCtD
Ketorolac—Drowsiness—Methotrexate—systemic scleroderma	0.000314	0.000354	CcSEcCtD
Ketorolac—Rash—Azathioprine—systemic scleroderma	0.000314	0.000353	CcSEcCtD
Ketorolac—Dermatitis—Azathioprine—systemic scleroderma	0.000313	0.000353	CcSEcCtD
Ketorolac—Flushing—Prednisone—systemic scleroderma	0.000313	0.000353	CcSEcCtD
Ketorolac—Headache—Azathioprine—systemic scleroderma	0.000312	0.000351	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000311	0.000351	CcSEcCtD
Ketorolac—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000351	CcSEcCtD
Ketorolac—Dizziness—Leflunomide—systemic scleroderma	0.000311	0.00035	CcSEcCtD
Ketorolac—Renal failure—Methotrexate—systemic scleroderma	0.000309	0.000348	CcSEcCtD
Ketorolac—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000346	CcSEcCtD
Ketorolac—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000307	0.000345	CcSEcCtD
Ketorolac—Stomatitis—Methotrexate—systemic scleroderma	0.000306	0.000345	CcSEcCtD
Ketorolac—Angiopathy—Prednisone—systemic scleroderma	0.000306	0.000345	CcSEcCtD
Ketorolac—Conjunctivitis—Methotrexate—systemic scleroderma	0.000305	0.000344	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000344	CcSEcCtD
Ketorolac—Immune system disorder—Prednisone—systemic scleroderma	0.000305	0.000343	CcSEcCtD
Ketorolac—Pain—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000341	CcSEcCtD
Ketorolac—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000341	CcSEcCtD
Ketorolac—Arrhythmia—Prednisone—systemic scleroderma	0.000301	0.000339	CcSEcCtD
Ketorolac—Sweating—Methotrexate—systemic scleroderma	0.000301	0.000339	CcSEcCtD
Ketorolac—Haematuria—Methotrexate—systemic scleroderma	0.0003	0.000337	CcSEcCtD
Ketorolac—Vomiting—Leflunomide—systemic scleroderma	0.000299	0.000336	CcSEcCtD
Ketorolac—Alopecia—Prednisone—systemic scleroderma	0.000298	0.000336	CcSEcCtD
Ketorolac—Hypersensitivity—Lisinopril—systemic scleroderma	0.000297	0.000335	CcSEcCtD
Ketorolac—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000297	0.000335	CcSEcCtD
Ketorolac—Dizziness—Mycophenolic acid—systemic scleroderma	0.000296	0.000334	CcSEcCtD
Ketorolac—Epistaxis—Methotrexate—systemic scleroderma	0.000296	0.000334	CcSEcCtD
Ketorolac—Rash—Leflunomide—systemic scleroderma	0.000296	0.000334	CcSEcCtD
Ketorolac—Dermatitis—Leflunomide—systemic scleroderma	0.000296	0.000333	CcSEcCtD
Ketorolac—Mental disorder—Prednisone—systemic scleroderma	0.000296	0.000333	CcSEcCtD
Ketorolac—Nausea—Azathioprine—systemic scleroderma	0.000295	0.000333	CcSEcCtD
Ketorolac—Headache—Leflunomide—systemic scleroderma	0.000294	0.000331	CcSEcCtD
Ketorolac—Erythema—Prednisone—systemic scleroderma	0.000294	0.000331	CcSEcCtD
Ketorolac—Malnutrition—Prednisone—systemic scleroderma	0.000294	0.000331	CcSEcCtD
Ketorolac—Agranulocytosis—Methotrexate—systemic scleroderma	0.000293	0.00033	CcSEcCtD
Ketorolac—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000328	CcSEcCtD
Ketorolac—Asthenia—Lisinopril—systemic scleroderma	0.00029	0.000326	CcSEcCtD
Ketorolac—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000326	CcSEcCtD
Ketorolac—Pruritus—Lisinopril—systemic scleroderma	0.000286	0.000322	CcSEcCtD
Ketorolac—Vomiting—Mycophenolic acid—systemic scleroderma	0.000285	0.000321	CcSEcCtD
Ketorolac—Haemoglobin—Methotrexate—systemic scleroderma	0.000283	0.000319	CcSEcCtD
Ketorolac—Rash—Mycophenolic acid—systemic scleroderma	0.000283	0.000318	CcSEcCtD
Ketorolac—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000282	0.000318	CcSEcCtD
Ketorolac—Hepatitis—Methotrexate—systemic scleroderma	0.000282	0.000318	CcSEcCtD
Ketorolac—Haemorrhage—Methotrexate—systemic scleroderma	0.000282	0.000318	CcSEcCtD
Ketorolac—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000316	CcSEcCtD
Ketorolac—Headache—Mycophenolic acid—systemic scleroderma	0.000281	0.000316	CcSEcCtD
Ketorolac—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000315	CcSEcCtD
Ketorolac—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000315	CcSEcCtD
Ketorolac—Nausea—Leflunomide—systemic scleroderma	0.000279	0.000314	CcSEcCtD
Ketorolac—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000279	0.000314	CcSEcCtD
Ketorolac—Vision blurred—Prednisone—systemic scleroderma	0.000277	0.000312	CcSEcCtD
Ketorolac—Urethral disorder—Methotrexate—systemic scleroderma	0.000276	0.000311	CcSEcCtD
Ketorolac—Diarrhoea—Lisinopril—systemic scleroderma	0.000276	0.000311	CcSEcCtD
Ketorolac—Ill-defined disorder—Prednisone—systemic scleroderma	0.000273	0.000307	CcSEcCtD
Ketorolac—Visual impairment—Methotrexate—systemic scleroderma	0.000272	0.000306	CcSEcCtD
Ketorolac—Anaemia—Prednisone—systemic scleroderma	0.000272	0.000306	CcSEcCtD
Ketorolac—Agitation—Prednisone—systemic scleroderma	0.00027	0.000304	CcSEcCtD
Ketorolac—Angioedema—Prednisone—systemic scleroderma	0.000268	0.000302	CcSEcCtD
Ketorolac—Dizziness—Lisinopril—systemic scleroderma	0.000267	0.000301	CcSEcCtD
Ketorolac—Erythema multiforme—Methotrexate—systemic scleroderma	0.000267	0.0003	CcSEcCtD
Ketorolac—Nausea—Mycophenolic acid—systemic scleroderma	0.000266	0.0003	CcSEcCtD
Ketorolac—Malaise—Prednisone—systemic scleroderma	0.000265	0.000298	CcSEcCtD
Ketorolac—Vertigo—Prednisone—systemic scleroderma	0.000264	0.000297	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—systemic scleroderma	0.000264	0.000297	CcSEcCtD
Ketorolac—Syncope—Prednisone—systemic scleroderma	0.000263	0.000297	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—systemic scleroderma	0.000263	0.000296	CcSEcCtD
Ketorolac—Cardiac disorder—Methotrexate—systemic scleroderma	0.000262	0.000295	CcSEcCtD
Ketorolac—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000293	CcSEcCtD
Ketorolac—Loss of consciousness—Prednisone—systemic scleroderma	0.000258	0.000291	CcSEcCtD
Ketorolac—Vomiting—Lisinopril—systemic scleroderma	0.000257	0.000289	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—systemic scleroderma	0.000256	0.000288	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—systemic scleroderma	0.000255	0.000287	CcSEcCtD
Ketorolac—Rash—Lisinopril—systemic scleroderma	0.000255	0.000287	CcSEcCtD
Ketorolac—Convulsion—Prednisone—systemic scleroderma	0.000255	0.000287	CcSEcCtD
Ketorolac—Dermatitis—Lisinopril—systemic scleroderma	0.000254	0.000286	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000254	0.000286	CcSEcCtD
Ketorolac—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000286	CcSEcCtD
Ketorolac—Hypertension—Prednisone—systemic scleroderma	0.000254	0.000286	CcSEcCtD
Ketorolac—Chills—Methotrexate—systemic scleroderma	0.000253	0.000285	CcSEcCtD
Ketorolac—Headache—Lisinopril—systemic scleroderma	0.000253	0.000285	CcSEcCtD
Ketorolac—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00025	0.000282	CcSEcCtD
Ketorolac—Myalgia—Prednisone—systemic scleroderma	0.00025	0.000282	CcSEcCtD
Ketorolac—Arthralgia—Prednisone—systemic scleroderma	0.00025	0.000282	CcSEcCtD
Ketorolac—Anxiety—Prednisone—systemic scleroderma	0.000249	0.000281	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—systemic scleroderma	0.000249	0.000281	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000248	0.00028	CcSEcCtD
Ketorolac—Discomfort—Prednisone—systemic scleroderma	0.000247	0.000278	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—systemic scleroderma	0.000247	0.000278	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—systemic scleroderma	0.000245	0.000276	CcSEcCtD
Ketorolac—Erythema—Methotrexate—systemic scleroderma	0.000245	0.000276	CcSEcCtD
Ketorolac—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000273	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—systemic scleroderma	0.00024	0.000271	CcSEcCtD
Ketorolac—Nausea—Lisinopril—systemic scleroderma	0.00024	0.00027	CcSEcCtD
Ketorolac—Anaphylactic shock—Prednisone—systemic scleroderma	0.00024	0.00027	CcSEcCtD
Ketorolac—Oedema—Prednisone—systemic scleroderma	0.00024	0.00027	CcSEcCtD
Ketorolac—Infection—Prednisone—systemic scleroderma	0.000238	0.000268	CcSEcCtD
Ketorolac—Back pain—Methotrexate—systemic scleroderma	0.000237	0.000267	CcSEcCtD
Ketorolac—Shock—Prednisone—systemic scleroderma	0.000236	0.000266	CcSEcCtD
Ketorolac—Nervous system disorder—Prednisone—systemic scleroderma	0.000235	0.000265	CcSEcCtD
Ketorolac—Tachycardia—Prednisone—systemic scleroderma	0.000234	0.000264	CcSEcCtD
Ketorolac—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000263	CcSEcCtD
Ketorolac—Skin disorder—Prednisone—systemic scleroderma	0.000233	0.000262	CcSEcCtD
Ketorolac—Hyperhidrosis—Prednisone—systemic scleroderma	0.000232	0.000261	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—systemic scleroderma	0.000231	0.000261	CcSEcCtD
Ketorolac—Anorexia—Prednisone—systemic scleroderma	0.000229	0.000257	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000228	0.000257	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—systemic scleroderma	0.000227	0.000256	CcSEcCtD
Ketorolac—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000253	CcSEcCtD
Ketorolac—Rash—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000251	CcSEcCtD
Ketorolac—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000251	CcSEcCtD
Ketorolac—Headache—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00025	CcSEcCtD
Ketorolac—Malaise—Methotrexate—systemic scleroderma	0.000221	0.000249	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—systemic scleroderma	0.000221	0.000248	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—systemic scleroderma	0.00022	0.000247	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000218	0.000246	CcSEcCtD
Ketorolac—Insomnia—Prednisone—systemic scleroderma	0.000217	0.000244	CcSEcCtD
Ketorolac—Paraesthesia—Prednisone—systemic scleroderma	0.000215	0.000242	CcSEcCtD
Ketorolac—Cough—Methotrexate—systemic scleroderma	0.000214	0.000241	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—systemic scleroderma	0.000213	0.00024	CcSEcCtD
Ketorolac—Dyspepsia—Prednisone—systemic scleroderma	0.000211	0.000238	CcSEcCtD
Ketorolac—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000237	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—systemic scleroderma	0.000209	0.000235	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—systemic scleroderma	0.000209	0.000235	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—systemic scleroderma	0.000209	0.000235	CcSEcCtD
Ketorolac—Decreased appetite—Prednisone—systemic scleroderma	0.000208	0.000235	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000208	0.000234	CcSEcCtD
Ketorolac—Fatigue—Prednisone—systemic scleroderma	0.000207	0.000233	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—systemic scleroderma	0.000206	0.000233	CcSEcCtD
Ketorolac—Constipation—Prednisone—systemic scleroderma	0.000205	0.000231	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—systemic scleroderma	0.000202	0.000228	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—systemic scleroderma	0.0002	0.000226	CcSEcCtD
Ketorolac—Infection—Methotrexate—systemic scleroderma	0.000199	0.000224	CcSEcCtD
Ketorolac—Feeling abnormal—Prednisone—systemic scleroderma	0.000198	0.000222	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—systemic scleroderma	0.000196	0.000221	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000196	0.000221	CcSEcCtD
Ketorolac—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000196	0.000221	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—systemic scleroderma	0.000195	0.000219	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000194	0.000218	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—systemic scleroderma	0.000191	0.000215	CcSEcCtD
Ketorolac—Urticaria—Prednisone—systemic scleroderma	0.00019	0.000214	CcSEcCtD
Ketorolac—Abdominal pain—Prednisone—systemic scleroderma	0.00019	0.000213	CcSEcCtD
Ketorolac—Body temperature increased—Prednisone—systemic scleroderma	0.00019	0.000213	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—systemic scleroderma	0.000187	0.000211	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000183	0.000206	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—systemic scleroderma	0.000181	0.000204	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—systemic scleroderma	0.00018	0.000203	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—systemic scleroderma	0.000179	0.000201	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—systemic scleroderma	0.000178	0.000201	CcSEcCtD
Ketorolac—Hypersensitivity—Prednisone—systemic scleroderma	0.000177	0.000199	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—systemic scleroderma	0.000176	0.000199	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—systemic scleroderma	0.000174	0.000196	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000173	0.000195	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—systemic scleroderma	0.000173	0.000195	CcSEcCtD
Ketorolac—Asthenia—Prednisone—systemic scleroderma	0.000172	0.000194	CcSEcCtD
Ketorolac—Pain—Methotrexate—systemic scleroderma	0.000171	0.000193	CcSEcCtD
Ketorolac—Pruritus—Prednisone—systemic scleroderma	0.00017	0.000191	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—systemic scleroderma	0.000165	0.000186	CcSEcCtD
Ketorolac—Diarrhoea—Prednisone—systemic scleroderma	0.000164	0.000185	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000164	0.000185	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—systemic scleroderma	0.000159	0.000179	CcSEcCtD
Ketorolac—Dizziness—Prednisone—systemic scleroderma	0.000159	0.000179	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—systemic scleroderma	0.000158	0.000178	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—systemic scleroderma	0.000158	0.000178	CcSEcCtD
Ketorolac—Vomiting—Prednisone—systemic scleroderma	0.000152	0.000172	CcSEcCtD
Ketorolac—Rash—Prednisone—systemic scleroderma	0.000151	0.00017	CcSEcCtD
Ketorolac—Dermatitis—Prednisone—systemic scleroderma	0.000151	0.00017	CcSEcCtD
Ketorolac—Headache—Prednisone—systemic scleroderma	0.00015	0.000169	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—systemic scleroderma	0.000148	0.000166	CcSEcCtD
Ketorolac—Asthenia—Methotrexate—systemic scleroderma	0.000144	0.000162	CcSEcCtD
Ketorolac—Nausea—Prednisone—systemic scleroderma	0.000142	0.00016	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—systemic scleroderma	0.000142	0.00016	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—systemic scleroderma	0.000137	0.000154	CcSEcCtD
Ketorolac—Dizziness—Methotrexate—systemic scleroderma	0.000132	0.000149	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—systemic scleroderma	0.000127	0.000143	CcSEcCtD
Ketorolac—Rash—Methotrexate—systemic scleroderma	0.000126	0.000142	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—systemic scleroderma	0.000126	0.000142	CcSEcCtD
Ketorolac—Headache—Methotrexate—systemic scleroderma	0.000126	0.000141	CcSEcCtD
Ketorolac—Nausea—Methotrexate—systemic scleroderma	0.000119	0.000134	CcSEcCtD
